Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.
Cumulus Oncology has raised $11.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Cumulus Oncology's investors include Scottish Enterprise, Eos, Scottish National Investment Bank.
Cumulus Oncology is headquartered in Edinburgh, United Kingdom.
Cumulus Oncology develops anti-cancer therapies for clinical settings in areas of high unmet need.
Cumulus Oncology is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cumulus Oncology — Funding & Investors." VCBacked, January 8, 2024, https://www.vcbacked.co/company/cumulus-oncology. Accessed July 31, 2026.
VCBacked. (2024). Cumulus Oncology — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/cumulus-oncology
{{cite web |title=Cumulus Oncology — Funding & Investors |url=https://www.vcbacked.co/company/cumulus-oncology |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated